TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 3 | 1 | 4 | -3 | -7 | -11 | -7 | 41 | 27 | 7 |
| P | %wins | 75 | 25 | 50 | 50 | 75 | 50 | 54 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/9/14 17:29 | 7/8/14 | GBIM | Globeimmune Inc | DE | Health | Drug | Pharmaceutical Preparations | Morgenthaler Partners VII LP | CA | T | P.d | 1,300 | 10.00 | 4 | 130 | 32 | 530 | D | 17 | 1 | -8 | -33 | -36 | -47 | -87 | ||||||||
7/23/13 19:12 | 7/23/13 | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Morgenthaler Partners VII LP | CA | T | P.d | 1,200 | 17.00 | 33 | 71 | 3 | 2,510 | D | -12 | -21 | -37 | -44 | 40 | -18 | |||||||||
11/16/06 14:54 | 11/10/06 | THRM | Thermage Inc | DE | Health | ElcMd | Electromedical & Electrothera | Morgenthaler Partners VII LP | CA | T | P.a | 338 | 7.00 | 1 | 48 | New | 48 | D | 174 | 61 | 9 | 19 | -5 | -7 | -1 | 0 | 0 | 4 | 11 | 25 | 88 | 108 | |
11/14/06 14:03 | 11/10/06 | THRM | Thermage Inc | DE | Health | ElcMd | Electromedical & Electrothera | Morgenthaler Partners VII LP | CA | T | P | 344 | 7.00 | 1 | 49 | New | 49 | D | 168 | 57 | 10 | 30 | -7 | -6 | 0 | -1 | 0 | -2 | 16 | 26 | 83 | 106 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |